The role of viable but non-infectious developmental forms in chlamydial biology

Affiliations

¹ Department of Pathobiology, Institute of Veterinary Pathology, University of Zurich Zurich, Switzerland.
² Department of Immunology and Microbiology, Wayne State University School of Medicine Michigan, MI, USA.
³ Department of Molecular and Clinical Infectious Diseases, University Hospital Schleswig-Holstein/Campus Lübeck Lübeck, Germany.
⁴ Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University Johnson City, TN, USA.

Editorial

Nicole Borel et al. Front Cell Infect Microbiol. 2014.

. 2014 Jul 24:4:97.

doi: 10.3389/fcimb.2014.00097. eCollection 2014.

¹ Department of Pathobiology, Institute of Veterinary Pathology, University of Zurich Zurich, Switzerland.
² Department of Immunology and Microbiology, Wayne State University School of Medicine Michigan, MI, USA.
³ Department of Molecular and Clinical Infectious Diseases, University Hospital Schleswig-Holstein/Campus Lübeck Lübeck, Germany.
⁴ Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University Johnson City, TN, USA.

No abstract available

Keywords: aberrant bodies; chronic disease; obligate intracellular; the chlamydial stress response; viable but non-infectious.

References

1. Aiyar A., Quayle A. J., Buckner L. R., Sherchand S. P., Chang T. L., Zea A. H., et al. (2014). Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections. Front. Cell. Infect. Microbiol. 4:72 10.3389/fcimb.2014.00072 - DOI - PMC - PubMed
1. Bavoil P. M. (2014). What's in a word: the use, misuse, and abuse of the word “persistence” in Chlamydia biology. Front. Cell. Infect. Microbiol. 4:27 10.3389/fcimb.2014.00027 - DOI - PMC - PubMed
1. Bonner C. A., Byrne G. I., Jensen R. A. (2014). Chlamydia exploit the mammalian tryptophan-depletion defense strategy as a counter-defensive cue to trigger a survival state of persistence. Front. Cell. Infect. Microbiol. 4:17 10.3389/fcimb.2014.00017 - DOI - PMC - PubMed
1. Campbell L. A., Rosenfeld M. E. (2014). Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. Front. Cell. Infect. Microbiol. 4:34 10.3389/fcimb.2014.00034 - DOI - PMC - PubMed
1. De Benedetti S., Bühl H., Gaballah A., Klöckner A., Otten C., Schneider T., et al. (2014). Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae. Front. Cell. Infect. Microbiol. 4:19 10.3389/fcimb.2014.00019 - DOI - PMC - PubMed